Get the Stockscreener App
2.96
4.59%
+0.13
First Wave BioPharma Inc Stock (FWBI) Forecast
The First Wave BioPharma Inc (FWBI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $152.70, representing a +5,059% increase from the current price of $2.96. The highest analyst price target is $169.34, and the lowest is $136.05.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FWBI Price Target
Average 242.57
(+8,095% Upside)
Is First Wave BioPharma Inc (FWBI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.78 | Neutral |
| STOCH(9,6) | 81.72 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.2133 | Buy |
| ADX(14) | 22.97 | Neutral |
| William %R | -15.43 | Sell |
| CCI(14) | 123.51 | Buy |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.804
Buy
|
2.8649
Buy
|
| MA20 |
2.8055
Buy
|
2.9593
Buy
|
| MA50 |
3.7584
Sell
|
3.5081
Sell
|
| MA100 |
4.4673
Sell
|
3.5787
Sell
|
| MA200 |
2.4657
Buy
|
3.2913
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, FWBI could be considered a Moderate Sell, with 17 technical analysis indicators signaling 7 Buy signals, 8 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on FWBI, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.78 indicates that FWBI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 81.72 indicates that FWBI is oversold. This means that FWBI price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that FWBI is oversold. This suggests that FWBI price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.97 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 123.51 indicates that FWBI is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term FWBI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about First Wave BioPharma Inc financial reports and earnings history, First Wave BioPharma Inc (FWBI) stock could reach $37.62 by 2030, $1,805.62 by 2040 and $372.70 by 2050. See the projected annual prices until 2050 of the First Wave BioPharma Inc stock below:
- First Wave BioPharma Inc (FWBI) is expected to reach an average price of $587.24 in 2035, with a high prediction of $644.84 and a low estimate of $587.38. This indicates an $19,739% rise from the last recorded price of $2.96.
- First Wave BioPharma Inc (FWBI) stock is projected to chart a bullish course in 2040, with an average price target of $1,738.67, representing an $58,639% surge from its current level. The forecast ranges from a conservative $1,740.84 to a sky-high $1,805.62.
- Our analysts predict First Wave BioPharma Inc (FWBI) to jump 114.11K% by 2045, soaring from $3,383.50 to an average price of $3,380.53, potentially reaching $3,390.44. While $3,383.50 is the low estimate, the potential upside is significant.
- First Wave BioPharma Inc (FWBI) stock is expected to climb by 2050, reaching an average of $280.37, a $9,372% jump from its current level. However, a wide range of estimates exists, with high and low targets of $372.70 and $280.54, respectively, highlighting the market's uncertainty.
First Wave BioPharma Inc Stock (FWBI) Year by Year Forecast
First Wave BioPharma Inc Stock (FWBI) Price Forecast for 2024
Our forecast for FWBI stock price in 2024 now indicates an average price target of $173.61 with a high forecast of $344.79 and a low forecast of $2.42. The average prediction reflects an increase of +5,765% from the last recorded price of $2.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $209.24 | $136.05 | $169.34 | +6,969% |
| July, 2024 | $237.43 | $217.94 | $203.83 | +7,921% |
| August, 2024 | $171.57 | $208.32 | $225.43 | +5,696% |
| September, 2024 | $244.32 | $181.62 | $217.26 | +8,154% |
| October, 2024 | $253.60 | $238.31 | $238.90 | +8,468% |
| November, 2024 | $308.50 | $290.97 | $292.75 | +10,322% |
| December, 2024 | $347.11 | $357.97 | $344.79 | +11,627% |
First Wave BioPharma Inc Stock (FWBI) Price Forecast for 2025
First Wave BioPharma Inc Stock (FWBI) is expected to reach an average price of $290.10 in 2025, with a high prediction of $349.09 and a low estimate of $231.12. This indicates an +9,701% rise from the last recorded price of $2.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $344.22 | $346.22 | $344.78 | +11,529% |
| February, 2025 | $358.90 | $353.13 | $349.09 | +12,025% |
| March, 2025 | $341.30 | $346.31 | $348.98 | +11,430% |
| April, 2025 | $338.38 | $339.08 | $342.15 | +11,332% |
| May, 2025 | $334.40 | $335.17 | $340.31 | +11,197% |
| June, 2025 | $322.93 | $323.42 | $329.89 | +10,810% |
| July, 2025 | $306.81 | $308.07 | $319.54 | +10,265% |
| August, 2025 | $294.99 | $295.20 | $302.99 | +9,866% |
| September, 2025 | $279.05 | $279.95 | $287.12 | +9,327% |
| October, 2025 | $261.87 | $262.40 | $272.71 | +8,747% |
| November, 2025 | $247.68 | $247.87 | $257.83 | +8,268% |
| December, 2025 | $230.73 | $231.12 | $244.03 | +7,695% |
First Wave BioPharma Inc Stock (FWBI) Price Forecast for 2026
The predicted value for First Wave BioPharma Inc (FWBI) in 2026 is set at an average of $133.23. Estimates vary from a peak of $226.12 to a trough of $40.35, indicating an +4,401% surge from the present price of $2.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $216.19 | $216.36 | $226.12 | +7,204% |
| February, 2026 | $202.60 | $202.70 | $212.54 | +6,745% |
| March, 2026 | $188.54 | $188.66 | $198.96 | +6,270% |
| April, 2026 | $171.58 | $171.61 | $184.89 | +5,697% |
| May, 2026 | $157.40 | $157.40 | $167.98 | +5,217% |
| June, 2026 | $142.87 | $142.93 | $153.72 | +4,727% |
| July, 2026 | $125.01 | $125.02 | $139.29 | +4,123% |
| August, 2026 | $110.62 | $110.62 | $121.39 | +3,637% |
| September, 2026 | $92.56 | $92.59 | $107.00 | +3,027% |
| October, 2026 | $72.90 | $74.65 | $88.95 | +2,363% |
| November, 2026 | $58.76 | $59.56 | $69.20 | +1,885% |
| December, 2026 | $38.16 | $40.35 | $54.87 | +1,189% |
First Wave BioPharma Inc Stock (FWBI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for First Wave BioPharma Inc (FWBI) is $391.83, with a high forecast of $779.89 and a low forecast of $3.7775. This indicates an +13,138% increase from the last price of $2.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $27.22 | $27.39 | $33.10 | +819.70% |
| February, 2027 | $14.63 | $14.74 | $23.49 | +394.40% |
| March, 2027 | $585.62 | $3.7775 | $486.31 | +19,684% |
| April, 2027 | $750.00 | $664.80 | $634.50 | +25,238% |
| May, 2027 | $718.03 | $744.64 | $710.87 | +24,158% |
| June, 2027 | $716.66 | $721.47 | $721.76 | +24,111% |
| July, 2027 | $692.04 | $663.54 | $673.75 | +23,280% |
| August, 2027 | $701.02 | $712.14 | $691.98 | +23,583% |
| September, 2027 | $734.34 | $695.01 | $726.95 | +24,709% |
| October, 2027 | $791.58 | $749.71 | $779.89 | +26,643% |
| November, 2027 | $768.01 | $768.85 | $761.28 | +25,846% |
| December, 2027 | $750.93 | $752.49 | $755.79 | +25,269% |
First Wave BioPharma Inc Stock (FWBI) Price Forecast for 2028
In 2028, First Wave BioPharma Inc (FWBI) is projected to reach an average price of $578.73, with a high projection of $735.79 and a low estimate of $421.67. This indicates an +19,452% rise from the last price of $2.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $738.43 | $739.92 | $735.79 | +24,847% |
| February, 2028 | $717.34 | $716.21 | $728.52 | +24,134% |
| March, 2028 | $694.89 | $696.15 | $708.80 | +23,376% |
| April, 2028 | $667.27 | $667.97 | $685.24 | +22,443% |
| May, 2028 | $634.26 | $634.39 | $657.19 | +21,328% |
| June, 2028 | $606.20 | $606.47 | $627.04 | +20,380% |
| July, 2028 | $574.66 | $576.83 | $598.38 | +19,314% |
| August, 2028 | $540.83 | $540.96 | $567.87 | +18,171% |
| September, 2028 | $513.61 | $513.75 | $533.48 | +17,252% |
| October, 2028 | $485.32 | $485.35 | $506.07 | +16,296% |
| November, 2028 | $449.42 | $449.67 | $478.06 | +15,083% |
| December, 2028 | $421.50 | $421.67 | $442.22 | +14,140% |
First Wave BioPharma Inc Stock (FWBI) Price Forecast for 2029
The 2029 price forecast for First Wave BioPharma Inc Stock (FWBI) is $229.62 on average, with a high prediction of $414.23 and a low estimate of $45.01. This represents an +7,657% increase from the previous price of $2.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $385.85 | $385.89 | $414.23 | +12,935% |
| February, 2029 | $358.03 | $358.09 | $378.55 | +11,996% |
| March, 2029 | $329.42 | $329.45 | $350.80 | +11,029% |
| April, 2029 | $300.74 | $300.75 | $322.20 | +10,060% |
| May, 2029 | $264.68 | $264.73 | $293.04 | +8,842% |
| June, 2029 | $235.90 | $235.91 | $257.41 | +7,870% |
| July, 2029 | $207.13 | $207.15 | $228.67 | +6,898% |
| August, 2029 | $167.43 | $168.60 | $199.89 | +5,556% |
| September, 2029 | $139.08 | $139.14 | $150.79 | +4,598% |
| October, 2029 | $101.28 | $101.61 | $130.03 | +3,322% |
| November, 2029 | $70.88 | $70.90 | $93.31 | +2,294% |
| December, 2029 | $44.92 | $45.01 | $63.37 | +1,417% |
First Wave BioPharma Inc Stock (FWBI) Price Forecast for 2030
First Wave BioPharma Inc Stock (FWBI) is expected to reach an average price of $617.02 in 2030, with a high forecast of $1,223.83 and a low forecast of $10.20. This signifies an +20,745% surge from the last price of $2.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $23.91 | $10.20 | $37.62 | +707.78% |
| February, 2030 | $1,189.66 | $1,098.18 | $1,139.26 | +40,091% |
| March, 2030 | $1,245.13 | $1,193.55 | $1,205.23 | +41,965% |
| April, 2030 | $1,214.51 | $1,225.01 | $1,223.83 | +40,931% |
| May, 2030 | $1,142.62 | $1,179.37 | $1,218.09 | +38,502% |
| June, 2030 | $1,186.55 | $1,145.47 | $1,166.69 | +39,986% |
| July, 2030 | $1,159.81 | $1,151.72 | $1,146.03 | +39,083% |
| August, 2030 | $1,185.89 | $1,187.55 | $1,172.85 | +39,964% |
| September, 2030 | $1,195.68 | $1,206.54 | $1,214.98 | +40,295% |
| October, 2030 | $1,156.77 | $1,158.77 | $1,180.15 | +38,980% |
| November, 2030 | $1,142.63 | $1,144.07 | $1,147.23 | +38,502% |
| December, 2030 | $1,096.21 | $1,101.23 | $1,124.05 | +36,934% |
4.27%
2.59%
Cap:
|
Volume (24h):